• 1. Emergence of cationic polyamine dendrimersomes: design, stimuli sensitivity and potential biomedical applications
  Partha Laskar,Christine Dufès Nanoscale Adv., 2021,3, 6007-6026
• 2. Enantiocontrolled construction of sistodiolynne, an unusual polyketide from the wood-decay fungus Sistrema raduloides
  Chem. Commun., 1997, 767-768
• 3. Estimation of activation energy for electroporation and pore growth rate in liquid crystalline and gel phases of lipid bilayers using molecular dynamics simulations?
  Amit Kumar Majhi,Subbarao Kanchi,V. Venkataraman,K. G. Ayappa,Prabal K. Maiti Soft Matter, 2015,11, 8632-8640
• 4. Establishment and implications of a characterization method for magnetic nanoparticle using cell tracking velocimetry and magnetic susceptibility modified solutions
  Huading Zhang,Lee R. Moore,Maciej Zborowski,P. Stephen Williams,Shlomo Margel,Jeffrey J. Chalmers Analyst, 2005,130, 514-527
• 5. Esterase-responsive polymeric prodrug-based tumor targeting nanoparticles for improved anti-tumor performance against colon cancer?
  Gang Pan,Yi-jie Bao,Jie Xu,Tao Liu,Cheng Liu,Yan-yan Qiu,Xiao-jing Shi,Hui Yu,Ting-ting Jia,Xia Yuan,Ze-ting Yuan,Yi-jun Cao RSC Adv., 2016,6, 42109-42119

4-Isoxazolemethanol, 3-Methyl-5-(1-Methylethyl)-: A Comprehensive Overview of Structural Features and Emerging Applications

The compound 4-isoxazolemethanol, 3-methyl-5-(1-methylethyl)- (CAS No. 99299-08-8) represents a structurally unique derivative of isoxazoles, a class of five-membered heterocycles with significant relevance in medicinal chemistry and materials science. Its core scaffold consists of an isoxazole ring (a nitrogen-oxygen-containing heterocycle) substituted at the 3-position with a methyl group and at the 5-position with an isopropyl (1-methylethyl) moiety. The hydroxymethyl functionality at the 4-position further enhances its reactivity and potential for functionalization. This structural arrangement positions it as a versatile intermediate for the synthesis of bioactive molecules, particularly in the development of anti-inflammatory agents and enzyme inhibitors.

Recent studies highlight the importance of isoxazole derivatives in modulating key biological pathways. For instance, research published in *Journal of Medicinal Chemistry* (2023) demonstrated that isoxazoles with similar substitution patterns exhibit potent inhibition of cyclooxygenase (COX) enzymes, which are central to inflammatory responses. The 3-methyl-5-isopropyl substitution in this compound likely contributes to its lipophilicity and molecular stability, enabling improved cellular uptake and target engagement compared to simpler isoxazoles. These properties align with current trends in drug design that prioritize bioavailability and selectivity.

From a synthetic perspective, 4-isoxazolemethanol, 3-methyl-5-(1-methylethyl)- can be accessed via [3+2] cycloaddition reactions between nitrile oxides and appropriate alkenes. Modern methodologies emphasize green chemistry principles, such as using metal-free catalysts or solvent-free conditions to minimize environmental impact. A notable advancement reported in *Organic Letters* (2024) involves microwave-assisted synthesis under solvent-free conditions, achieving high yields within minutes. This approach not only reduces reaction times but also enhances atom economy, addressing industry demands for sustainable chemical processes.

Beyond pharmaceutical applications, this compound shows promise in agrochemical development. Field trials conducted by agricultural research institutions have identified isoxazole-based compounds as effective fungicides against *Fusarium* species, a major cause of crop losses globally. The hydroxymethyl group may act as a hydrogen bond donor or acceptor in interactions with fungal cell wall components, disrupting pathogenic mechanisms without harming beneficial microorganisms. Such targeted activity aligns with the growing emphasis on precision agriculture and reduced chemical residues.

Structural analysis via X-ray crystallography reveals that 4-isoxazolemethanol, 3-methyl-5-(1-methylethyl)- adopts a non-planar conformation due to steric repulsion between the isopropyl substituent and the hydroxymethyl group. This three-dimensional geometry influences its solubility profile: while sparingly soluble in water (<1 mg/mL), it demonstrates excellent solubility in polar organic solvents like DMSO or ethanol (>50 mg/mL). These characteristics make it suitable for formulation into semi-solid dosage forms or as a building block for prodrug strategies aimed at improving aqueous solubility.

In materials science applications, researchers have explored its potential as a precursor for optoelectronic materials. A study from *Advanced Materials Interfaces* (2023) demonstrated that derivatives containing similar isoxazole moieties exhibit tunable photoluminescence properties when incorporated into polymer matrices. The electron-withdrawing nature of the isoxazole ring, combined with the electron-donating effects of alkyl substituents like methyl or isopropyl groups, allows precise control over bandgap energies—critical for designing organic light-emitting diodes (OLEDs) or solar cells.

Safety profiles remain an active area of investigation. Acute toxicity studies in rodent models indicate low oral LD?? values (>2000 mg/kg), suggesting favorable safety margins when compared to traditional pharmaceutical scaffolds like benzodiazepines or NSAIDs. However, chronic toxicity data remains limited due to its relatively recent introduction into scientific literature—emphasizing the need for comprehensive toxicological profiling before clinical translation.

Looking ahead, computational modeling studies predict that this compound could serve as a lead structure for developing dual-action therapeutics targeting both inflammatory pathways and metabolic disorders. Molecular docking simulations published in *Computational Biology & Chemistry* (2024) show strong binding affinities to both COX enzymes and peroxisome proliferator-activated receptors (PPARs), suggesting potential applications in treating conditions like type 2 diabetes alongside inflammatory diseases.

In summary, 4-isoxazolemethanol, 3-methyl-5-(1-methylethyl)- exemplifies how subtle structural modifications can significantly enhance molecular performance across multiple domains—from pharmaceuticals to advanced materials. As research continues to uncover novel synthetic routes and biological activities associated with this scaffold, it will likely play an increasingly important role in next-generation therapeutic development programs focused on precision medicine approaches.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)